Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO to Prevent Transfusions in Cyanotic CHD
NCT02564796Phase 2Terminated
- Sponsor
- University of California, San Diego
- Start
- Nov 2016
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of epoetin alfa in anemia, sponsored by University of California, San Diego. Primary endpoint: Number of Transfusions Needed at 4 months. Started Nov 2016; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02564796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02564796.